1Mehra MR, Venture HO, Chambers RB, et al. The prognostic impact of immunosupression and cellular rejection on cardiac allograft vasculopathy : time for a reappraisal. J Heart Lung Transplant, 1997, 16: 743-751.
2Yacoub M, Alivizatos P, Khaghani A, et al. The use of cyclosporine, azathioprine, and antithymocyte globulin with or without low-dose steroids for immunosuppression of cardiac transplant patients. Transplant Proc, 1985, 17:221-222.
3Keogh A, Macdonald P, Mundy J, et al. Five-year followupof a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation. J Heart Lung Transplam, 1992, 11(3 part 1):550-556.
4Taylor DO, Bristow MR, O'Connell JB, et al. Improved longterm survival after heart transplantation predicted by successful early withdrawal from maintenance corticosterold therapy. J Heart Iung Transplant, 1996, 15:1039-1046.
5Katz MR, Barnhart GR, Szentpetery S,et al.Are steroids essential for successful maintenance of immunosuppression in heart transplantation?J Heart Lung Transplant,1987,6:293-297.
6Prieto M, Lake KD, Pritzker MR,et al.OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients J Heart Lung Transplant,1991,10:901-911.
7Gregory DP, Stephanie LO, David OT, et al. Corticostereidfree maintenanceafter immunosuppression after heart transplantatim:feasibility and bebeficial effects. J Heart Lung Transplant, 1992, 11:403-414.
8Olivari MT, Jessen ME, Baldwin BJ, et al. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation. J Heart Lung Transplant, 1995, 14(1 part 1):127-135.
9Kobashigawa JA, Katznelson S, Lake H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med, 1995, 333:621-627.
10Timothy EO, Thomas W, Sherry AC, et al. Steroid-free maintenance immunosuppression after heart transplantation. Ann Thorac Surg, 2001,72: 102-106.
